CNPAX
Price
$70.42
Change
+$0.04 (+0.06%)
Updated
Aug 15 closing price
Net Assets
158.96B
GFDDX
Price
$104.90
Change
-$0.07 (-0.07%)
Updated
Aug 15 closing price
Net Assets
9.23B
Interact to see
Advertisement

CNPAX vs GFDDX

Header iconCNPAX vs GFDDX Comparison
Open Charts CNPAX vs GFDDXBanner chart's image
American Funds New Perspective 529A
Price$70.42
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets158.96B
Invesco Global R5
Price$104.90
Change-$0.07 (-0.07%)
VolumeN/A
Net Assets9.23B
CNPAX vs GFDDX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CNPAX vs. GFDDX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and GFDDX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 159B vs. GFDDX (9.23B). CNPAX pays higher dividends than GFDDX: CNPAX (0.48) vs GFDDX (0.00). CNPAX was incepted earlier than GFDDX: CNPAX (24 years) vs GFDDX (6 years). CNPAX (0.77) and GFDDX (0.74) have similar cost to investors . CNPAX is a more actively managed with annual turnover of: 24.00 vs. GFDDX (7.00). CNPAX has a lower initial minimum investment than GFDDX: CNPAX (250) vs GFDDX (1000000). CNPAX annual gain was more profitable for investors over the last year : 13.57 vs. GFDDX (0.55). CNPAX return over 5 years is better than : 39.09 vs. GFDDX (2.36).
CNPAXGFDDXCNPAX / GFDDX
Total Expense Ratio0.770.74104%
Annual Report Gross Expense Ratio0.770.74104%
Fund Existence24 years6 years-
Gain YTD15.3869.021171%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets159B9.23B1,723%
Annual Yield % from dividends0.480.00-
Returns for 1 year13.570.552,484%
Returns for 3 years35.297.70458%
Returns for 5 years39.092.361,655%
Returns for 10 years95.36N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETON17.040.34
+2.04%
Eton Pharmaceuticals
WLY39.560.15
+0.38%
John Wiley & Sons
OPXS11.750.03
+0.26%
Optex Systems Holdings
REVB2.58N/A
N/A
Revelation Biosciences Inc
CNM64.12-0.39
-0.60%
Core & Main